This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the
U.S. nonvascular stents market. Major topics covered by this report include a discussion of current and emerging nonvascular stenting technologies; a clinical overview of nonvascular conditions targeted by stenting (e.g., biliary GI, pulmonary, and urinary tract obstruction) and an analysis of the procedure volumes and market forecasts for biliary, GI, pulmonary, and urologic stenting systems in the U.S.
EXECUTIVE SUMMARY a. Nonvascular Stenting Systems b. Stent Design and Materials c. Products and Procedures i. Biliary Stenting ii. Gastrointestinal Stenting iii. Pulmonary Stenting iv. Urologic Stenting v. Combined Procedure Volumes Forecast d. Market Analysis i. Biliary Stents ii. Gastrointestinal Stents iii. Pulmonary Stents iv. Urologic Stents v. Combined Market Analysis Exhibit ES-1: 2010, Estimated Incidence of Nonvascular Conditions Targeted by Stenting Technologies Exhibit ES-2: Nonvascular Stenting, Procedure Volumes Forecast, 2009-2014 Exhibit ES-3: Nonvascular Stenting Systems, Market Forecast, 2009-2014 1. CURRENT AND EMERGING PERIPHERAL VASCULAR AND NONVASCULAR STENTING TECHNOLOGIES 1.1 Stent Design 1.1.1 Vascular Stents 1.1.2 Nonvascular Stents 1.1.3 Stent Deployment Mechanisms 1.2 Stent Materials 1.2.1 Metal Stents 220.127.116.11 Absorbable Magnesium Alloys 18.104.22.168 Cobalt Alloys 22.214.171.124 Nickel-Titanium Alloys 126.96.36.199 Stainless Steel 1.2.2 Standard Polymeric Stents 1.2.3 Biodegradable Polymeric Stents 1.3 Stent Coatings 1.3.1 Radiopacity Enhancement 1.3.2 Biocompatibility Enhancement 1.3.3 Active Therapeutic Enhancement 188.8.131.52 Drug-Eluting Stents 184.108.40.206.1 Antirestenotic Drug-Eluting Stents 220.127.116.11.2 Drug Delivery Techniques 1.3.4 Stent Coverings and Linings Exhibit 1-1: Selected Biomedical, Clinical, and Technical Stent Requirements Exhibit 1-2: Advantages and Disadvantages of Selected Vascular Stent Designs Exhibit 1-3: Advantages and Disadvantages of Metal Stent Materials Exhibit 1-4: Selected Polymeric Stent Materials Exhibit 1-5: Selected Characteristics of Antirestenosis Agents Used in Drug-Eluting Stents Exhibit 1-6: Advantages and Disadvantages of Nonresorbable and Biodegradable Polymeric Drug Carriers for Drug-Eluting Stents 2. CLINICAL OVERVIEW OF NONVASCULAR STENTS 2.1 Nonvascular Conditions Targeted by Stenting 2.1.1 Biliary Tract Obstruction 18.104.22.168 Clinical Indications 22.214.171.124 Implantation Techniques 126.96.36.199 Biliary Stent Types 188.8.131.52.1 Plastic Devices 184.108.40.206.2 Metal Devices 220.127.116.11 Procedure Volumes 2.1.2 Gastrointestinal Tract Obstruction 18.104.22.168 Colorectal Stenting 22.214.171.124.1 Clinical Indications 126.96.36.199.2 Technology 188.8.131.52.3 Implantation Techniques 184.108.40.206 Esophageal Stenting 220.127.116.11.1 Technology 18.104.22.168.2 Implantation Techniques 22.214.171.124 Procedure Volumes 2.1.3 Pulmonary Tract Obstruction 126.96.36.199 Clinical Indications 188.8.131.52 Types of Pulmonary Stenting Systems 184.108.40.206 Procedure Volumes 2.1.4 Urinary Tract Obstruction 220.127.116.11 Ureteral Obstruction 18.104.22.168.1 Urinary Stone Disease 22.214.171.124.2 Ureteral Strictures 126.96.36.199.3 Ureteral Stenting 188.8.131.52 Urethral Obstruction 184.108.40.206.1 Benign Prostatic Hyperplasia 220.127.116.11.2 Urethral Strictures 18.104.22.168.3 Urethral Stenting 22.214.171.124 Procedure Volumes Exhibit 2-1: 2010, Biliary Obstruction, Facts and Figures Exhibit 2-2: Biliary Stenting, Procedure Volumes Forecast, 2009-2014 Exhibit 2-3: 2010, Colorectal Obstruction, Facts and Figures Exhibit 2-4: 2010, Esophageal Obstruction, Facts and Figures Exhibit 2-5: Gastrointestinal Stenting, Procedure Volumes Forecast, 2009-2014 Exhibit 2-6: 2010, Pulmonary Tract Obstruction, Facts and Figures Exhibit 2-7: Pulmonary Stenting, Procedure Volumes Forecast, 2009-2014 Exhibit 2-8: 2010, Upper Urinary Tract Obstruction, Facts and Figures Exhibit 2-9: 2010, Lower Urinary Tract Obstruction, Facts and Figures Exhibit 2-10: Urologic Stenting, Procedure Volumes Forecast, 2009-2014 3. NONVASCULAR STENTS MARKET 3.2.1 Biliary Stenting Systems 126.96.36.199 Products 188.8.131.52 Market Forecast 184.108.40.206 Competitive Analysis 3.2.2 Gastrointestinal Stenting Systems 220.127.116.11 Products 18.104.22.168 Market Forecast 22.214.171.124 Competitive Analysis 3.2.3 Pulmonary Stenting Systems 126.96.36.199 Products 188.8.131.52 Market Forecast 184.108.40.206 Competitive Analysis 3.2.4 Urologic Stenting Systems 220.127.116.11 Ureteral Stenting Products 18.104.22.168 Urethral Stenting Products 22.214.171.124 Market Forecast 126.96.36.199 Competitive Analysis Exhibit 3-1: Nonvascular Stenting, Procedure Volumes Forecast, 2009-2014 Exhibit 3-2: Nonvascular Stents, Market Forecast, 2009-2014 Exhibit 3-3: 2011, Selected Metal and Plastic Biliary Stents Exhibit 3-4: Biliary Stents, Market Forecast, 2009-2014 Exhibit 3-5: 2010, Biliary Stents Market, Share by Supplier Exhibit 3-6: 2011, Selected Colorectal Stents Exhibit 3-7: 2011, Selected Esophageal Stents Exhibit 3-8: Metal Gastrointestinal Stents, Market Forecast, 2009-2014 Exhibit 3-9: 2010, Colorectal Stents Market, Share by Supplier Exhibit 3-10: 2010, Metal Esophageal Stents Market, Share by Supplier Exhibit 3-11: 2011, Selected Pulmonary Stents Exhibit 3-12: Pulmonary Stents, Market Forecast, 2009-2014 Exhibit 3-13: 2010, Pulmonary Stents Market, Share by Supplier Exhibit 3-14: 2011, Selected Ureteral Stents Exhibit 3-15: 2011, Selected Prostatic Stents Exhibit 3-16: Urologic Stents, Market Forecast, 2009-2014 Exhibit 3-17: 2010, Ureteral Stents Market, Share by Supplier Exhibit 3-18: 2010, Urethral Stents Market, Share by Supplier 4. COMPANY PROFILES 4.1 AbbeyMoor Medical, Inc. 4.2 American Medical Systems, Inc. 4.3 Boston Scientific Corporation 4.4 Bryan Corporation 4.5 Cook Group, Inc. 4.6 Cordis Corporation/Johnson & Johnson 4.7 Gyrus ACMI/Olympus Corporation 4.8 Hood Laboratories, Inc. 4.9 Merit Endotek/Merit Medical Systems, Inc. Appendix: Company Listing